Table 1 Characteristics of the health facilities in study districts in Uganda
From: Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Characteristics (N = 195) | n (%) |
|---|---|
Health facility type | Â |
   Hospital | 8 (4.1) |
   Health centre IV | 12 (6.2) |
   Health centre III | 56 (28.7) |
   Health centre II* | 119 (61.0) |
Health facility ownership | Â |
   Government | 172 (88.2) |
   Non-government | 12 (6.2) |
   Mission | 11 (5.6) |
Equipment and services at health facility | Â |
   Weighing scale | 178 (91.3) |
   Thermometer | 146 (74.9) |
   Functional microscopy | 50 (25.6) |
Wall charts exposed | Â |
   Any chart recommending artemether-lumefantrine use | 93 (47.7) |
Chart on uncomplicated malaria | 68 (34.9) |
Chart on new treatment policy | 35 (18.0) |
Integrated management of childhood illnesses chart | 33 (16.9) |
Availability of artemether-lumefantrine on the survey day | Â |
   Any tablets of artemether-lumefantrine | 169 (86.7) |
Artemether-lumefantrine 6 tablets pack | 162 (83.1) |
Artemether-lumefantrine 12 tablets pack | 140 (71.8) |
Artemether-lumefantrine 18 tablets pack | 75 (38.5) |
Artemether-lumefantrine 24 tablets pack | 124 (63.6) |
Availability of other antimalarial drugs on the survey day†|  |
   Chloroquine (any formulation) | 149 (76.8) |
   Sulphadoxine-pyrimethamine (any formulation) | 170 (87.6) |
   Quinine (tablets) | 58 (29.9) |
   Amodiaquine (any formulation) | 4 (2.1) |
   Artesunate tablets | 8 (4.1) |